Protective effects of adeno-associated virus mediated brain-derived neurotrophic factor expression on retinal ganglion cells in diabetic rats

Cellular and Molecular Neurobiology

Volumn 32, Issue 3, 2012, Pages 467-475

  Gong, Yan ^a   Chang, Zhan Ping ^b   Ren, Ruo Tong ^c   Wei, Shi Hui ^a   Zhou, Huan Fen ^a   Chen, Xiao Fei ^a   Hou, Bao Ke ^a   Jin, Xin ^a   Zhang, Mao Nian ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Aerospace 731 Hospital   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Adeno associated virus (AAV); Brain derived neurotrophic factor (BDNF); Diabetic retinopathy; Gene therapy; Streptzotocin(STZ)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; PARVOVIRUS VECTOR;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; DRUG EFFICACY; EVOKED VISUAL RESPONSE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; LATENT PERIOD; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; VIRAL GENE DELIVERY SYSTEM;

ADENO-ASSOCIATED VIRUS; RATTUS;

EID: 84862802651     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-011-9779-x     Document Type: Article

References (61)

1. Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Squinto SP, Yancopoulos GD, Lindsay RM (1995) A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374:450-453
2. Akhtar N, Akram M, Asif HM, Usmanghani K, Ali Shah SM, Ahmad Rao S, Uzair M, Shaheen G, Ahmad K (2011) Gene therapy: a review article. Fly1 J Med Plants Res 5(10):1812-1817
3. Algan M, Ziegler O, Gehin P, Got I, Raspiller A, Weber M, Genton P, Saudax E, Drouin P (1989) Visual evoked potentials in diabetic patients. Diabetes Care 12:227-229 (Pubitemid 19071493)
4. American Diabetes Association (2007) Diagnosis and classification of diabetes mellitus. Diabetes Care 30(Supp1):S42-S47
5. Baillart JP, L'examen FM (1954) Rapport à la Société d'Ophthalmologie de Paris. Bull Soc Ophthalmol Fr 4(Suppl):I-LXVII
6. Bloomgarden ZT (2008) Diabetic retinopathy. Diabetes Care 31:1080-1083
7. Bresnick GH, Korth K, Groo A, Palta M (1984) Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report. Arch Ophthalmol 102:1307-1311 (Pubitemid 14071831)
8. Caputo S, Di Leo MA, Falsini B, Ghirlanda G, Porciatti V, Minella A, Greco AV (1990) Evidence for early impairment of macular function with pattern ERG in type I diabetic patients. Diabetes Care 13:412-418 (Pubitemid 20109477)
9. Center for disease control and prevention (2011) National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. U.S department of health and human services, Center for disease control and prevention, Atlanta
10. Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, Fuller JH (1998) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB controlled trial of lisinopril in insulin-dependent diabetes mellitus. Lancet 351:28-31 (Pubitemid 28020163)
11. Cobb WA, Morton HB (1953) A new component of the human electroretinogram. J Physiol (Lond) 123:36-37
12. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
13. Di Leo MA, Falsini B, Caputo S, Ghirlanda G, Porciatti V, Greco AV (1990) Spatial frequency-selective losses with pattern electro-retinogram in type 1 (insulin-dependent) diabetic patients without retinopathy. Diabetologia 33:726-730
14. Ewing FM, Deary IJ, Strachan MW, Frier BM (1998) Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision. Endocr Rev 19:462-476 (Pubitemid 29116016)
15. Fletcher EL, Phipps JA, Ward MM, Puthussery T, Wilkinson-Berka JL (2007) Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr Pharm Des 13:2699-2712 (Pubitemid 47423662)
16. Franchi A, Magni R, Lodigiani L, Cordella M (1987) VEP pattern after photostress: an index of macular function. Graefes Arch Clin Exp Ophthalmol 225:291-294 (Pubitemid 17092224)
17. Giraldi A, Persson K, Werkstrom V, Alm P, Wagner G, Andersson KE (2001) Effects of diabetes on neurotransmission in rat vaginal smooth muscle. Int J Impot Res 13:58-66 (Pubitemid 32506073)
18. Green M, Loewenstein PM (2006) Human adenoviruses: propagation, purification, quantification, and storage. Curr Protoc Microbiol, Chap. 14: unit 14C, p 11
19. Grimm D, Kay MA, Kleinschmidt JA (2003) Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vector of serotypes 1 to 6. Mol Ther 7:839-850 (Pubitemid 36790261)
20. Halliday AM (1993) The visual evoked potential in healthy subjects. In: Halliday AM (ed) Evoked potentials in clinical testing, 2nd edn. Churchill Livingstone, Edinburgh, pp 57-113
21. Holemans K, Van Bree R, Verhaeghe J, Meurrens K, Van Assche FA (1997) Maternal semistarvation and streptozotocin-diabetes in rats have different effects on the in vivo glucose uptake by peripheral tissues in their female adult offspring. J Nutr 127:1371-1376 (Pubitemid 27284006)
22. Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677-736 (Pubitemid 32695243)
23. Jehle T, Wingert K, Dimitriu C, Meschede W, Lasseck J, Bach M, Lagreze WA (2008) Quantification of ischemic damage in the rat retina: a comparative study using evoked potentials, electroretinography, and histology. Invest Ophthalmol Vis Sci 49:1056-1064
24. Johnson JE, Barde YA, Schwab M, Thoenen H (1986) Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci 6:3031-3038 (Pubitemid 16026084)
25. Karunanayake EH, Hearse DJ, Mellows G (1975) The metabolic fate and elimination of streptozotocin. Biochem Soc Trans 3:410-414
26. Kern TS, Barber AJ (2008) Retinal ganglion cells in diabetes. J Physiol 586:4401-4408
27. Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP (2007) Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 56:373-379
28. Kohzaki K, Vingrys AJ, Bui BV (2008) Early inner retinal dysfunction in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 49:3595-3604
29. Laquis S, Chaudhary P, Sharma SC (1998) The patterns of retinal ganglion cell death in hypertensive eyes. Brain Res 784:100-104 (Pubitemid 28137853)
30. Lovasik JV (1983) An electrophysiological investigation of the macular photostress test. Invest Ophthalmol Vis Sci 24:437-441
31. Lovasik JV, Kergoat H (1993) Electroretinographic results and ocular vascular perfusion in type 1 diabetes. Invest Ophthalmol Vis Sci 34:1731-1743 (Pubitemid 23120248)
32. Luu CD, Szental JA, Lee SY, Lavanya R, Wong TY (2010) Correlation between retinal oscillatory potentials and retinal vascular caliber in type 2 diabetes. Invest Ophthalmol Vis Sci 51:482-486
33. Machemer R, Sugita G, Tano Y (1979) Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 77:171-180 (Pubitemid 10072805)
34. Mansford KR, Opie L (1968) Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet 1:670-671
35. Maritim AC, Sanders RA, Watkins JB III (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24-38 (Pubitemid 36410972)
36. Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, Drummond K, Donnelly S, Goodyer P, Gubler MC et al (2009) Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 361:40-51
37. Moreo G, Mariani E, Pizzamiglio G, Colucci GB (1995) Visual evoked potentials in NIDDM: a longitudinal study. Diabetologia 38:573-576
38. Mosci C, Polizzi A, Grillo N, Capris P, Zingirian M (1986) Ottimizzazione del test del recupero maculare nello studio dei soggetti diabetici. Bol Ocul 65:347-356
39. OzkayaYG, AgarA, Hacioglu G, Yargicoglu P (2007) Exercise improves visual deficits tested by visual evoked potentials in streptozotocin-induced diabetic rats. Tohoku J Exp Med 213:313-321
40. Pan CH, Chen SS (1992) Pattern shift visual evoked potentials in diabetes mellitus. Gaoxiong Yi Xue Ke Xue Za Zhi 8:374-383
41. Papakostopoulos D, Hart JC, Corrall RJ, Harney B (1996) The scotopic electroretinogram to blue flashes and pattern reversal visual evoked potentials in insulin dependent diabetes. Int J Psychophysiol 21:33-43 (Pubitemid 26059461)
42. Parisi V (2001) Electrophysiological evaluation of the macular cone adaptation: VEP after photostress. A review. Doc Ophthalmol 102:251-262
43. Park K, Ryu SB, Park YI, Ahn K, Lee SN, Nam JH (2001) Diabetes mellitus induces vaginal tissue fibrosis by TGF-beta 1 expression in the rat model. J Sex Marital Ther 27:577-587 (Pubitemid 32802793)
44. Parrilla-Reverter G, Agudo M, Sobrado-Calvo P, Salinas-Navarro M, Villegas-Perez MP, Vidal-Sanz M (2009) Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study. Exp Eye Res 89:32-41
45. Phipps JA, Yee P, Fletcher EL, Vingrys AJ (2006) Rod photoreceptor dysfunction in diabetes: activation, deactivation, and dark adaptation. Invest Ophthalmol Vis Sci 47:3187-3194 (Pubitemid 351639799)
46. Puvanendran K, Devathasan G, Wong PK (1983) Visual evoked responses in diabetes. J Neurol Neurosurg Psychiatry 46:643-647 (Pubitemid 13073797)
47. Raman PG, Sodani A, George B (1997)Astudy of visual evoked potential changes in diabetes mellitus. Int J Diab Dev Ctries 17:69-73
48. Rancz EA, Franks KM, Schwarz MK, Pichler B, Schaefer AT, Margrie TW (2011) Transfection via whole-cell recording in vivo: bridging single-cell physiology, genetics and connectomics. Nat Neurosci 14:527-532
49. Seki M, Tanaka T, Nawa H, Usui T, Fukuchi T, Ikeda K, Abe H, Takei N (2004) Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 53:2412-2419 (Pubitemid 39145597)
50. Shevtsova Z, Malik JMI, Michel U, Bähr M, Kügler S (2004) Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo. Exp Physiol 90:53-59
51. Shpak AA, Gavrilova NA, Poliakova MA (2010) Brain-derived neurotrophic factor in diabetic retinopathy and asymptomatic edema of the optic nerve head. Vestn oftalmol 126:7-10
52. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317:703-713
53. Usta MF, Bivalacqua TJ, Yang DY, Ramanitharan A, Sell DR, Viswanathan A, Monnier VM, Hellstrom WJ (2003) The protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats. J Urol 170:1437-14422
54. Vadala M, Anastasi M, Lodato G, Cillino S (2002) Electroretinographic oscillatory potentials in insulin-dependent diabetes patients: a long-term follow-up. Acta Ophthalmol Scand 80:305-309 (Pubitemid 34649933)
55. Vavra JJ, Deboer C, Dietz A, Hanka LJ, Sokolski WT (1959) Streptozotocin, a new antibacterial antibiotic. Antibiot Annu 7:230-235
56. Weymouth AE, Vingrys AJ (2008) Rodent electroretinography: methods for extraction and interpretation of rod and cone responses. Prog Retin Eye Res 27:1-44
57. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053 (Pubitemid 38579764)
58. Wu G, Weiter JJ, Santos S, Ginsburg L, Villalobos R (1990) The macular photostress test in diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol 108:1556-1558 (Pubitemid 20377543)
59. Yonemura D, Aoki T, Tsuzuki K (1962) Electroretinogram in diabetic retinopathy. Arch Ophthalmol 68:19-24
60. Zhao J, Pang S, Che G (2009) Specificity and sensitivity of visual evoked potentials P100 latency to different events exercise. Health 1:47-50
61. Zingirian M, Polizzi A, Grillo N (1985) The macular recovery test after photostress in normal and diabetic subjects. Acta Diabetol Lat 22:169-172 (Pubitemid 15242103)